UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current concepts of celiac disease pathogenesis

Gastroenterology (New York, N.Y. 1943), 2000-07, Vol.119 (1), p.234-242

Schuppan, Detlef

2000

Volltextzugriff (PDF)

Herbal medicine in the treatment of liver diseases

Digestive and liver disease, 2007-04, Vol.39 (4), p.293-304

2007

Volltextzugriff (PDF)

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Advanced drug delivery reviews, 2017-11, Vol.121, p.43-56

2017

Volltextzugriff (PDF)

Antifibrotic therapies in the liver

Seminars in liver disease, 2015-05, Vol.35 (2), p.184-198

2015

Volltextzugriff (PDF)

Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B

Journal of gastroenterology and hepatology, 2015-04, Vol.30 (4), p.756-762

2015

Volltextzugriff (PDF)

P629 LONG-ACTING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISM MITIGATES INFLAMMATION AND FIBROSIS IN MODELS OF NASH AND BILIARY FIBROSIS

Journal of hepatology, 2014-04, Vol.60 (1), p.S278-S278

2014

Volltextzugriff (PDF)

In vivo cell specific gene silencing in the liver using novel siRNA-loaded biodegradable nanohydrogel particles

Zeitschrift für Gastroenterologie, 2016-08, Vol.54 (8)

Schuppan, D

2016

Volltextzugriff (PDF)

The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity

Clinical microbiology and infection, 2013-09, Vol.19 (9), p.E386-E394

2013

Volltextzugriff (PDF)

Fibrosis is not just fibrosis – basement membrane modelling and collagen metabolism differs between hepatitis B‐ and C‐induced injury

Alimentary pharmacology & therapeutics, 2016-12, Vol.44 (11-12), p.1242-1252

2016

Volltextzugriff (PDF)

Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver

Journal of controlled release, 2018-01, Vol.269, p.258-265

2018

Volltextzugriff (PDF)

84 IN VIVO INHIBITION OF HEPATIC FIBROSIS BY C12-200-LIPOSOMES CARRYING ANTIFIBROTIC SIRNAS

Journal of hepatology, 2012-04, Vol.56, p.S37-S37

2012

Volltextzugriff (PDF)

Rapamycin and Zoledronic Acid strongly inhibit growth of advanced murine hepatocellular carcinoma via activation of innate and adaptive immunity

Journal of hepatology, 2018, Vol.68, p.S665-S666

2018

Volltextzugriff (PDF)

The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor

Journal of controlled release, 2019-02, Vol.296, p.250-257

2019

Volltextzugriff (PDF)

FRI-082 - Zoledronic Acid suppresses tumour associated macrophages andmyeloid derived suppressor cells in murine HCC

Journal of hepatology, 2018-04, Vol.68, p.S398-S398

2018

Volltextzugriff (PDF)

The hedgehog pathway regulates remodelling responses to biliary obstruction in rats

Gut, 2008-09, Vol.57 (9), p.1275-1282

2008

Volltextzugriff (PDF)

Matrix as a Modulator of Hepatic Fibrogenesis

Seminars in liver disease, 2001-08, Vol.21 (3), p.351-372

2001

Volltextzugriff (PDF)

Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity

Zeitschrift fur Gastroenterologie, 2014-07, Vol.52 (7), p.711

2014

Volltextzugriff (PDF)

Rapamycin and Zoledronic acid exert a potent antifibrotic effect in murine biliary fibrosis

Journal of hepatology, 2018, Vol.68, p.S398

2018

Volltextzugriff (PDF)

Evolving therapies for liver fibrosis

The Journal of clinical investigation, 2013-05, Vol.123 (5), p.1887-1901

2013

Volltextzugriff (PDF)

A prospective comparative study of five measures of gluten‐free diet adherence in adults with coeliac disease

Alimentary pharmacology & therapeutics, 2007-11, Vol.26 (9), p.1227-1235

2007

Volltextzugriff (PDF)

Thyroid‐associated orbitopathy is linked to gastrointestinal autoimmunity

Clinical and experimental immunology, 2014-10, Vol.178 (1), p.57-64

2014

Volltextzugriff (PDF)

IL10 promoter haplotypes may contribute to altered cytokine expression and systemic inflammation in celiac disease

Clinical immunology (Orlando, Fla.), 2018-05, Vol.190, p.15-21

2018

Volltextzugriff (PDF)

Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver

Digestive and liver disease, 2009-08, Vol.41 (8), p.541-550

2009

Volltextzugriff (PDF)

Hepatitis C and liver fibrosis

Cell death and differentiation, 2003-01, Vol.10 (S1), p.S59-S67

2003

Volltextzugriff (PDF)

Autoantibodies to tissue transglutaminase as predictors of celiac disease

Gastroenterology (New York, N.Y. 1943), 1998-12, Vol.115 (6), p.1317-1321

1998

Volltextzugriff (PDF)

1 – 25 von 762

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(700)
Mit Volltextzugriff
(577)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(317)
Life Sciences & Biomedicine
(313)
Humans
(282)
Biological And Medical Sciences
(182)
Medical Sciences
(158)
Gastroenterology & Hepatology
(145)
Male
(138)
Animals
(130)
Female
(119)
Adult
(89)
Middle Aged
(84)
Gastroenterology. Liver. Pancreas. Abdomen
(78)
Gastroenterology And Hepatology
(75)
Rats
(75)
Aged
(48)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(48)
Other Diseases. Semiology
(47)
Collagen
(43)
Liver - Pathology
(42)
Collagen - Metabolism
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current concepts of celiac disease pathogenesis

Herbal medicine in the treatment of liver diseases

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Antifibrotic therapies in the liver

Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B

P629 LONG-ACTING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISM MITIGATES INFLAMMATION AND FIBROSIS IN MODELS OF NASH AND BILIARY FIBROSIS

In vivo cell specific gene silencing in the liver using novel siRNA-loaded biodegradable nanohydrogel particles

The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity

Fibrosis is not just fibrosis – basement membrane modelling and collagen metabolism differs between hepatitis B‐ and C‐induced injury

Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver

84 IN VIVO INHIBITION OF HEPATIC FIBROSIS BY C12-200-LIPOSOMES CARRYING ANTIFIBROTIC SIRNAS

Rapamycin and Zoledronic Acid strongly inhibit growth of advanced murine hepatocellular carcinoma via activation of innate and adaptive immunity

The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor

FRI-082 - Zoledronic Acid suppresses tumour associated macrophages andmyeloid derived suppressor cells in murine HCC

The hedgehog pathway regulates remodelling responses to biliary obstruction in rats

Matrix as a Modulator of Hepatic Fibrogenesis

Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity

Rapamycin and Zoledronic acid exert a potent antifibrotic effect in murine biliary fibrosis

Evolving therapies for liver fibrosis

A prospective comparative study of five measures of gluten‐free diet adherence in adults with coeliac disease

Thyroid‐associated orbitopathy is linked to gastrointestinal autoimmunity

IL10 promoter haplotypes may contribute to altered cytokine expression and systemic inflammation in celiac disease

Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver

Hepatitis C and liver fibrosis

Autoantibodies to tissue transglutaminase as predictors of celiac disease

Suchergebnisse filtern